A17 is a bile acid analog with anti-non-alcoholic steatohepatitis (NASH) and anti-inflammatory activities. A17 reduces fatty acid (FA) uptake and promotes FA oxidation though inhibiting fatty acid translocase (Cd36) expression and activating AMPKalpha. A17 can be used for NASH research[1].
Molekulargewicht:
533.75
Reinheit:
99.4
CAS Nummer:
[2568186-47-8]
Formel:
C31H51NO6
Target-Kategorie:
AMPK
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten